{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T20:10:04Z","timestamp":1755893404068,"version":"3.44.0"},"publisher-location":"New York, NY, USA","reference-count":19,"publisher":"ACM","license":[{"start":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:00:00Z","timestamp":1715904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.acm.org\/publications\/policies\/copyright_policy#Background"}],"content-domain":{"domain":["dl.acm.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5,17]]},"DOI":"10.1145\/3673971.3674005","type":"proceedings-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T12:22:16Z","timestamp":1725884536000},"page":"158-163","update-policy":"https:\/\/doi.org\/10.1145\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Differential Methylation Analysis in Normal Breast Tissue Contralateral to Tumour Reveals PROM1 As a Potential Prognostic Biomarker"],"prefix":"10.1145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2229-0163","authenticated-orcid":false,"given":"Aya","family":"Nour","sequence":"first","affiliation":[{"name":"College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2743-2252","authenticated-orcid":false,"given":"Rafaa Al","family":"Alwani","sequence":"additional","affiliation":[{"name":"College of Science and Engineering, Hamad Bin Khalifa University, Qatar"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5247-1347","authenticated-orcid":false,"given":"Sara","family":"Alresheq","sequence":"additional","affiliation":[{"name":"College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3950-6618","authenticated-orcid":false,"given":"Muhammad","family":"Arif","sequence":"additional","affiliation":[{"name":"College of Science and Engineering, Hamad Bin Khalifa University, Qatar"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7033-3693","authenticated-orcid":false,"given":"Tanvir","family":"Alam","sequence":"additional","affiliation":[{"name":"College of Science and Engineering, Hamad Bin Khalifa University, Qatar"}]}],"member":"320","published-online":{"date-parts":[[2024,9,9]]},"reference":[{"key":"e_1_3_2_1_1_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_3_2_1_2_1","volume-title":"Current and future burden of breast cancer: Global statistics for 2020 and","author":"Arnold M","year":"2040","unstructured":"Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, 2022. Current and future burden of breast cancer: Global statistics for 2020 and 2040. The Breast. Dec;66:15\u201323."},{"key":"e_1_3_2_1_3_1","doi-asserted-by":"crossref","unstructured":"[3] de Almeida BP Apol\u00f3nio JD Binnie A Castelo-Branco P. 2019. Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers. BMC Cancer. Dec 12;19(1):219.","DOI":"10.1186\/s12885-019-5403-0"},{"key":"e_1_3_2_1_4_1","doi-asserted-by":"crossref","unstructured":"[4] Vietri M D'elia G Benincasa G Ferraro G Caliendo G Nicoletti G 2021. DNA methylation and breast cancer: A way forward (Review). Int J Oncol. Oct 29;59(5):98.","DOI":"10.3892\/ijo.2021.5278"},{"key":"e_1_3_2_1_5_1","doi-asserted-by":"crossref","unstructured":"[5] Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 23;490(7418):61\u201370.","DOI":"10.1038\/nature11412"},{"key":"e_1_3_2_1_6_1","doi-asserted-by":"crossref","unstructured":"[6] Sher G Salman NA Khan AQ Prabhu KS Raza A Kulinski M 2022. Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications. Semin Cancer Biol. Aug;83:152\u201365.","DOI":"10.1016\/j.semcancer.2020.08.009"},{"key":"e_1_3_2_1_7_1","doi-asserted-by":"crossref","unstructured":"[7] Teschendorff AE Gao Y Jones A Ruebner M Beckmann MW Wachter DL 2016. DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer. Nat Commun. Apr 29;7(1):10478.","DOI":"10.1038\/ncomms10478"},{"key":"e_1_3_2_1_8_1","doi-asserted-by":"crossref","unstructured":"[8] Muse ME Titus AJ Salas LA Wilkins OM Mullen C Gregory KJ 2020. Enrichment of CpG island shore region hypermethylation in epigenetic breast field cancerization. Epigenetics. Oct 2;15(10):1093\u2013106.","DOI":"10.1080\/15592294.2020.1747748"},{"key":"e_1_3_2_1_9_1","unstructured":"[9] Oliveros JC. Venny. 2007. An interactive tool for comparing lists with Venn's diagrams.."},{"key":"e_1_3_2_1_10_1","unstructured":"[10] Human Protein Atlas (HPA)."},{"key":"e_1_3_2_1_11_1","doi-asserted-by":"crossref","unstructured":"[11] Hu Z Liu H Zhang X Hong B Wu Z Li Q 2020. Promoter hypermethylation of CD133\/PROM1 is an independent poor prognosis factor for head and neck squamous cell carcinoma. Medicine. Mar;99(11):e19491.","DOI":"10.1097\/MD.0000000000019491"},{"key":"e_1_3_2_1_12_1","unstructured":"[12] The Human Protein Atlas-\u00a0 PROM1."},{"key":"e_1_3_2_1_13_1","doi-asserted-by":"crossref","unstructured":"[13] Saha SK Islam SMR Kwak KS Rahman MdS Cho SG. 2020. PROM1 and PROM2 expression differentially modulates clinical prognosis of cancer: a multiomics analysis. Cancer Gene Ther. Apr 5;27(3\u20134):147\u201367.","DOI":"10.1038\/s41417-019-0109-7"},{"key":"e_1_3_2_1_14_1","doi-asserted-by":"publisher","unstructured":"[14] Joseph C. Arshad M. Kurozomi S.\u00a0et al.\u00a02019. Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer.\u00a0Breast Cancer Res Treat\u00a0174 387\u2013399. https:\/\/doi.org\/10.1007\/s10549-018-05085-9","DOI":"10.1007\/s10549-018-05085-9"},{"key":"e_1_3_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-2018"},{"key":"e_1_3_2_1_16_1","doi-asserted-by":"publisher","unstructured":"[16] Song Y. Zhao B. Xu Y.\u00a0et al.\u00a02020. Prognostic significance of branched-chain amino acid transferase 1 and CD133 in triple-negative breast cancer.\u00a0BMC Cancer\u00a020 584. https:\/\/doi.org\/10.1186\/s12885-020-07070-2","DOI":"10.1186\/s12885-020-07070-2"},{"key":"e_1_3_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28263"},{"key":"e_1_3_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4123622"},{"key":"e_1_3_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00138"}],"event":{"name":"ICMHI 2024: 2024 8th International Conference on Medical and Health Informatics","acronym":"ICMHI 2024","location":"Yokohama Japan"},"container-title":["Proceedings of the 2024 8th International Conference on Medical and Health Informatics"],"original-title":[],"link":[{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3673971.3674005","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dl.acm.org\/doi\/pdf\/10.1145\/3673971.3674005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T19:47:17Z","timestamp":1755892037000},"score":1,"resource":{"primary":{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3673971.3674005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,17]]},"references-count":19,"alternative-id":["10.1145\/3673971.3674005","10.1145\/3673971"],"URL":"https:\/\/doi.org\/10.1145\/3673971.3674005","relation":{},"subject":[],"published":{"date-parts":[[2024,5,17]]},"assertion":[{"value":"2024-09-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}